The global African horse sickness treatment market was valued at around US$ 713.0 Million at the end of 2021. The market is projected to register a 17.0% CAGR and top a valuation of US$ 4,017.5 Million by 2032.
The key factors projected to drive the global market for African horse sickness treatment are increasing investments in R&D programmes to supply many preventative immunizations and recommendations made by regulatory organisations about species health.
The African horse sickness virus (AHSV) is the cause of the infectious, non-contagious disease known as African horse sickness (AHS), which can generate epidemic outbreaks. The World Organisation for Animal Health's (OIE's) Terrestrial Animal Health Code (Terrestrial Code) defines AHS as an AHSV infection of equids. AHS primarily affects domestic horses, while donkeys and wild equids, including zebras, can also contract the disease and spread it while showing less clinical symptoms.
In addition to an appropriate dietary plan and routine deworming, which are essential to horse health, a good vaccination programme can help prevent the spread of African horse sickness. The most effective and economical way to stop common infectious diseases in horses is through prevention programmes.
The prevention of horses from contracting the disease is advised as there is now no specific therapy for the treatment of African horse disease. Supportive treatment therapy is advised as the cure for African horse sickness.
| Attributes | Details |
|---|---|
| African Horse Sickness Treatment Market Value in 2021 | US$ 713.0 Million |
| African Horse Sickness Treatment Market Value in 2032 | US$ 4,017.5 Million |
| African Horse Sickness Treatment Market CAGR (2022 to 2032) | 17.0% |
Growing investments in R&D programmes to provide numerous preventative vaccinations and recommendations made by regulatory bodies regarding species health for African horse sickness treatment are the main factors anticipated to drive the global market for African horse sickness treatment. The primary element influencing the African horse sickness treatment market in all regions has been the availability of standard operating procedures and standards for the conditions associated with the disease. The treatment for African horse sickness is expanding, and several preventive immunizations are now being developed.
A solid vaccination schedule, along with a balanced diet and regular deworming, are preventive measures for treating African horse disease. A technologically advanced healthcare infrastructure and ongoing research projects with prominent vendors and international institutes to develop efficient vaccinations would help the global market for African horse sickness treatment. The market's growth is however influenced by favourable government regulations and higher disposable income due to improved public awareness about horse vaccination. All affirmatory factors are supposed to drive the market’s growth.
The global market for African horse sickness treatment is anticipated to be dominated by the North American market, and this dominance is anticipated to last for the duration of the forecast. The expansion of the industry for treating African horse sickness in this area has been largely driven by guidelines and standard operating procedures. The market for treating African horse sickness in the local market was dominated by the USA. The United States Department of Agriculture (USDA), a company, oversees the standard operating procedures for treating African horse disease in the USA.
The market for African horse sickness treatment is expanding, with considerable participation from European countries. The major market participants and established countries like the United Kingdom, Germany, France, and Italy are helping the European regional market grow significantly. The expansion of the market in the nation is being influenced by the increase in research activities and the accessibility of cutting-edge healthcare infrastructure.
Veterinary Serum & Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 17.0% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segment Covered | Product Type, End-Use, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | Veterinary Serum and Vaccine Research Institute; Onderstepoort Biological Products SOC Ltd |
| Customization | Available Upon Request |
The global African horse sickness treatment market is anticipated to register a CAGR of 17.0% during the forecast period.
Veterinary Serum & Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd., among others are some prominent African horse sickness treatment market players.
Explore Similar Insights
African Horse Sickness Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
